A detailed history of Intact Investment Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Intact Investment Management Inc. holds 284,200 shares of BMY stock, worth $15.1 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
284,200
Previous 58,800 383.33%
Holding current value
$15.1 Million
Previous $3.19 Million 270.2%
% of portfolio
0.49%
Previous 0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$40.25 - $52.99 $9.07 Million - $11.9 Million
225,400 Added 383.33%
284,200 $11.8 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $3.55 Million - $3.94 Million
-55,700 Reduced 48.65%
58,800 $3.76 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $4.9 Million - $5.55 Million
-74,500 Reduced 39.42%
114,500 $7.94 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $1.31 Million - $1.55 Million
-19,100 Reduced 9.18%
189,000 $13.6 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $52 - $30,736
400 Added 0.19%
208,100 $14.8 Million
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $1.27 Million - $1.4 Million
-17,500 Reduced 7.77%
207,700 $16 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $928,348 - $1.11 Million
-15,100 Reduced 6.28%
225,200 $16.4 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $96,534 - $112,536
-1,800 Reduced 0.74%
240,300 $15 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $272,182 - $318,826
4,600 Added 1.94%
242,100 $14.3 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $3.31 Million - $3.72 Million
55,700 Added 30.64%
237,500 $15 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $2.85 Million - $3.16 Million
49,700 Added 37.62%
181,800 $11 Million
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $2.52 Million - $2.95 Million
46,000 Added 53.43%
132,100 $7.76 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $1.54 Million - $2.24 Million
33,200 Added 62.76%
86,100 $4.79 Million
Q4 2019

Feb 18, 2020

BUY
$49.21 - $64.19 $2.6 Million - $3.4 Million
52,900 New
52,900 $3.39 Million
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $2.44 Million - $3.18 Million
-49,500 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $213,850 - $253,550
-5,000 Reduced 9.17%
49,500 $2.51 Million
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $1.21 Million - $1.44 Million
-26,800 Reduced 32.96%
54,500 $2.6 Million
Q4 2018

Jan 22, 2019

SELL
$48.76 - $63.23 $185,288 - $240,274
-3,800 Reduced 4.47%
81,300 $4.22 Million
Q3 2018

Oct 29, 2018

BUY
$55.19 - $62.25 $165,570 - $186,750
3,000 Added 3.65%
85,100 $5.28 Million
Q1 2018

May 08, 2018

BUY
$59.92 - $68.98 $4.51 Million - $5.19 Million
75,200 Added 1089.86%
82,100 $5.19 Million
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $381,087 - $439,806
6,900
6,900 $440,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Intact Investment Management Inc. Portfolio

Follow Intact Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Intact Investment Management Inc. with notifications on news.